This message was sent to ##Email##
|
| May 9, 2018 |
| |  | | |
|
|
|
| |
ASCT
The Centers for Medicare and Medicaid Services (CMS) recently published a letter offering clarification on how to calculate workload when a rapid on-site evaluation (ROSE) is conducted during a fine needle aspiration (FNA) procedure.
According to the letter, a slide assessment for specimen adequacy, that does not include a diagnosis, should not count as a slide examination and would not be counted toward an individual’s daily workload. The letter goes on to explain that workload limits should be set in accordance with CLIA regulations. To read the full text of the letter click here.
| 2018 Conference Thank You
|
    |
ASCT
ASCT would like to thank everyone who attended this year’s annual conference in Salt Lake City. We had a fantastic time and we can’t wait to see you next year in Puerto Rico!
| Date |
Event |
Location |
More information |
June 20, 2018 |
The Bethesda System for Cervical Cytology — Update and Beyond
|
Your PC |
Patricia G. Tiscornia-Wasserman, MD
Professor of Pathology and Cell Biology
Director of Cytopathology
Columbia University Medical Center
Melville, New York
Details
|
July 2018 |
Milan System for Salivary Gland FNA
|
Your PC |
Esther Diana Rossi, MD, PhD, MIAC
Division of Anatomic Pathology and Histology
Catholic University “Agostino Gemelli” School of Medicine
Rome, Italy
Details
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
May 3 - 5, 2019 |
2019 ASCT Annual Conference
|
San Juan, Puerto Rico |
Details |
Precision Vaccinations
Australian women have been fortunate to have had a government-sponsored cervical cancer vaccine program since 2007.
And 8 years later, the results are very positive.
Cervical cancer death rates in Australia have halved since the National Cervical Screening Program began in 1991. In 2015, there were 230 deaths caused by cervical cancer in Australia.
READ MORE
Medical Xpress
Research led by UNC School of Medicine student Wesley Stepp, Ph.D., shows how more detailed genetic testing of head and neck tumors could lead to more personalized treatments for patients. Stepp, first author of the study published in JAMA Otolaryngology-Head & Neck Surgery, said his method could lead to better outcomes for patients.
READ MORE
Advanced Science News
Over recent years, there has been much talk concerning the human papillomavirus, or HPV. HPV has been associated with numerous cancers, including cervical and throat cancer. While HPV is most commonly associated with cervical cancer in women, in men, HPV is most commonly associated with oral and oropharyngeal (throat) cancers. Throat cancers are the sixth most common cancer worldwide and have a fatality rate of nearly 40 percent each year.
READ MORE
Medical Xpress
Every year, 1.6 million people die of lung cancer. But if you think that these are just older heavy smokers, you're wrong.
READ MORE
FierceBiotech
Prostate cancer cells rely on protein synthesis to fuel their growth, but there can be too much of a good thing: Prostate tumors that are flooded with protein will actually die. Research has shown that treatment-resistant prostate cancer has a built-in stress response — an automatic brake that prevents protein synthesis from getting out of control and killing the cancer cells.
READ MORE
Futurity
As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
